ImageneBio Changes Certifying Accountant to 03 Life Sciences
Ticker: IMA · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1835579
| Field | Detail |
|---|---|
| Company | Imagenebio, INC. (IMA) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
ImageneBio swapped auditors to 03 Life Sciences, effective Aug 2, 2025.
AI Summary
ImageneBio, Inc. (formerly Ikena Oncology, Inc.) announced on August 2, 2025, a change in its certifying accountant to 03 Life Sciences. This change was effective as of August 2, 2025. The company's principal executive offices are located at 12526 High Bluff Drive, San Diego, California.
Why It Matters
A change in a company's auditor can signal shifts in financial reporting scrutiny or strategic direction. Investors should monitor future financial statements for any changes in accounting practices or disclosures.
Risk Assessment
Risk Level: low — This filing solely pertains to a change in the company's independent auditor, which is a routine administrative event.
Key Players & Entities
- ImageneBio, Inc. (company) — Registrant
- Ikena Oncology, Inc. (company) — Former Company Name
- 03 Life Sciences (company) — New Certifying Accountant
- August 2, 2025 (date) — Effective date of change
FAQ
Who is ImageneBio, Inc.'s new certifying accountant?
ImageneBio, Inc.'s new certifying accountant is 03 Life Sciences.
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of August 2, 2025.
What was ImageneBio, Inc.'s former name?
ImageneBio, Inc.'s former name was Ikena Oncology, Inc.
Where are ImageneBio, Inc.'s principal executive offices located?
ImageneBio, Inc.'s principal executive offices are located at 12526 High Bluff Drive, San Diego, California, 92130.
What is ImageneBio, Inc.'s IRS Employer Identification Number?
ImageneBio, Inc.'s IRS Employer Identification Number is 811697316.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding ImageneBio, Inc. (IMA).